Phoenix Clinical Research
At Phoenix Clinical Research, they take great pride in their commitment to delivering exceptional services, ensuring precision, and strict adherence to protocols through their unparalleled clinical trial monitoring expertise. Their efficient project management approach guarantees seamless coordination and timely execution of all trial aspects, setting them apart as a reliable partner. With a strong focus on excellence, integrity, and innovation, Phoenix CR strives to contribute significantly to cutting-edge healthcare solutions. Leveraging their in-depth understanding of the region’s regulatory landscape, they provide expert solutions encompassing protocol design, site selection, patient recruitment, and regulatory submissions. Clients can rely on Phoenix CR to navigate the complexities of clinical research with utmost professionalism and dedication.”
Learn more: www.phoenix-cr.com
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
June 26, 2025
June 30 – 4:00 PM to 5:15 PM (CET) xShare, an EU-funded project, strengthens procurement capabilities in digital health by translating the European Electronic Health Record Exchange Format (EEHRxF) into concrete requirements for tenders. This inaugural webinar presents key EU rules and promotes the procurement of interoperable solutions. It aims to raise awareness, share innovative […]
June 26, 2025
June 25–27 – JETRO – Japan External Trade Organization Pavilion – Osaka Booth Hall 6‑A, A‑0408 Philippe Haran – MD, is representing Telemedicine Technologies at the Japan Health Exhibition 2025, as a guest of Micron, Inc., a valued member of our CROAlliance partner. At Micron’s booth, he’s engaging with healthcare leaders and exploring collaboration opportunities […]
June 26, 2025
Applied Clinical Trials Online At a time when artificial intelligence (AI) is redefining industries at an unprecedented pace, the pharmaceutical sector stands on the brink of a progressive transformation. AI is not just a tool but a catalyst that promises to accelerate drug development timelines in ways we’ve never seen before. However, the true potential […]